A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the efficacy and safety of icatibant compared to
placebo in patients experiencing acute attacks of hereditary angioedema (HAE).